Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 9.785
-3.02 %
$ 1.2 B
Market Cap
54.6
P/E
DVAX - REVENUE
Revenue DVAX - Dynavax Technologies Corporation
277 M
LAST VALUE
-38.06%
2 YEAR CAGR
51.08%
5 YEAR CAGR
38.05%
10 YEAR CAGR